Overview

Candesartan Versus Propranolol for Migraine Prevention

Status:
Completed
Trial end date:
2012-03-01
Target enrollment:
Participant gender:
Summary
The main aim of the present study is to compare candesartan with propranolol for migraine prophylaxis.
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
Norwegian University of Science and Technology
Collaborators:
AstraZeneca
Kragerø Tablettproduksjon as, Norway
St. Olavs Hospital
Treatments:
Candesartan
Candesartan cilexetil
Propranolol